FY2024 Earnings Forecast for BioRem Issued By Cormark

BioRem Inc. (CVE:BRM) – Stock analysts at Cormark issued their FY2024 EPS estimates for BioRem in a research note issued on Tuesday, December 17th. Cormark analyst N. Boychuk forecasts that the company will post earnings of $0.19 per share for the year. Cormark currently has a “Moderate Buy” rating on the stock. Cormark also issued estimates for BioRem’s FY2025 earnings at $0.22 EPS and FY2026 earnings at $0.29 EPS.

BioRem Stock Performance

BioRem stock opened at C$3.14 on Friday. The business has a 50 day moving average of C$2.84 and a 200-day moving average of C$2.41. The company has a market capitalization of C$49.30 million, a P/E ratio of 14.95 and a beta of 0.85. BioRem has a 1 year low of C$0.95 and a 1 year high of C$3.39. The company has a debt-to-equity ratio of 48.97, a current ratio of 1.57 and a quick ratio of 1.08.

Insider Buying and Selling

In other news, Director Derek Webb sold 120,000 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of C$2.93, for a total transaction of C$351,600.00. 1.90% of the stock is currently owned by insiders.

About BioRem

BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs.